SignalEarnings

$VKTX. VIKING THERAPEUTICS

VKTX

$28.44

-0.77%

What changed

FQ3 FY2026 (ends Sep) | reported Oct 28: - Revenue: N/A - Adj EPS: $-1.55 vs $-1.06

Why it matters

FQ3 FY2026 (ends Sep) | reported Oct 28:

Sources

pipeline